Inovio Pharmaceuticals Inc (INO)
2.09
-0.19
(-8.33%)
USD |
NASDAQ |
Jan 08, 16:00
2.09
0.00 (0.00%)
After-Hours: 04:48
Inovio Pharmaceuticals SG&A Expense (Quarterly): 8.614M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Novavax Inc | 70.75M |
| CervoMed Inc | 2.211M |
| Abbott Laboratories | 2.895B |
| Baxter International Inc | 754.00M |
| Leap Therapeutics Inc | 2.94M |